DEVON, Pa., March 01, 2017 (GLOBE NEWSWIRE) — Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), a clinical-stage specialty pharmaceutical company dedicated to the development of innovative transdermal synthetic cannabinoid treatments, today announced that Armando Anido, Chairman and Chief Executive Officer, will present at upcoming investor conferences in March, including:
- 29th Annual ROTH Conference in Orange County, CA, on March 13, 2017 at 1:00 pm PT (4:00 pm ET)
- Oppenheimer Co. 27th Annual Healthcare Conference in New York City on March 22, 2017 at 10:20 am ET
To listen to a webcast of the presentations live, please visit the Investor Relations page of www.zynerba.com. A replay of each webcast will be available for 90 days following the conclusion of the respective event.
About Zynerba Pharmaceuticals, Inc.
Zynerba Pharmaceuticals (NASDAQ:ZYNE) is a clinical-stage specialty pharmaceutical company focused on developing and commercializing proprietary next-generation synthetic cannabinoid therapeutics formulated for transdermal delivery.